vs
CHEGG, INC（CHGG）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是CHEGG, INC的1.0倍（$75.5M vs $72.7M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -49.4%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $-15.5M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs -35.4%）
Chegg是一家总部位于美国加利福尼亚州圣克拉拉的教育科技公司，依托人工智能技术，为学生提供作业辅导、数字及实体教材租赁、在线辅导等各类学生服务，目前拥有660万订阅用户，也因被指协助学生作弊、违反学术诚信而广受批评。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
CHGG vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.0倍
$72.7M
营收增速更快
PBYI
高出77.1%
-49.4%
自由现金流更多
PBYI
多$29.9M
$-15.5M
两年增速更快
PBYI
近两年复合增速
-35.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $72.7M | $75.5M |
| 净利润 | — | — |
| 毛利率 | 57.3% | 69.3% |
| 营业利润率 | -47.2% | 22.7% |
| 净利率 | — | — |
| 营收同比 | -49.4% | 27.7% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $-0.30 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CHGGPBYI
| Q4 25 | $72.7M | $75.5M | ||
| Q3 25 | $77.7M | $54.5M | ||
| Q2 25 | $105.1M | $52.4M | ||
| Q1 25 | $121.4M | $46.0M | ||
| Q4 24 | $143.5M | $59.1M | ||
| Q3 24 | $136.6M | $80.5M | ||
| Q2 24 | $163.1M | $47.1M | ||
| Q1 24 | $174.3M | $43.8M |
净利润CHGGPBYI
| Q4 25 | — | — | ||
| Q3 25 | $-17.5M | $8.8M | ||
| Q2 25 | $-35.7M | $5.9M | ||
| Q1 25 | $-17.5M | $3.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-212.6M | $20.3M | ||
| Q2 24 | $-616.9M | $-4.5M | ||
| Q1 24 | $-1.4M | $-4.8M |
毛利率CHGGPBYI
| Q4 25 | 57.3% | 69.3% | ||
| Q3 25 | 59.2% | 77.7% | ||
| Q2 25 | 66.3% | 76.5% | ||
| Q1 25 | 55.5% | 77.1% | ||
| Q4 24 | 68.2% | 76.4% | ||
| Q3 24 | 68.2% | 63.9% | ||
| Q2 24 | 72.2% | 77.4% | ||
| Q1 24 | 73.3% | 75.5% |
营业利润率CHGGPBYI
| Q4 25 | -47.2% | 22.7% | ||
| Q3 25 | -22.0% | 17.6% | ||
| Q2 25 | -34.7% | 12.7% | ||
| Q1 25 | -23.9% | 8.7% | ||
| Q4 24 | -19.0% | 22.6% | ||
| Q3 24 | -162.7% | 27.4% | ||
| Q2 24 | -297.3% | -4.6% | ||
| Q1 24 | -1.4% | -5.3% |
净利率CHGGPBYI
| Q4 25 | — | — | ||
| Q3 25 | -22.5% | 16.2% | ||
| Q2 25 | -33.9% | 11.2% | ||
| Q1 25 | -14.4% | 6.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | -155.7% | 25.2% | ||
| Q2 24 | -378.1% | -9.6% | ||
| Q1 24 | -0.8% | -11.0% |
每股收益（稀释后）CHGGPBYI
| Q4 25 | $-0.30 | $0.26 | ||
| Q3 25 | $-0.16 | $0.17 | ||
| Q2 25 | $-0.33 | $0.12 | ||
| Q1 25 | $-0.17 | $0.06 | ||
| Q4 24 | $-0.03 | $0.40 | ||
| Q3 24 | $-2.05 | $0.41 | ||
| Q2 24 | $-6.01 | $-0.09 | ||
| Q1 24 | $-0.01 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $72.8M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $119.6M | $130.3M |
| 总资产 | $278.0M | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资CHGGPBYI
| Q4 25 | $72.8M | $97.5M | ||
| Q3 25 | $96.4M | $94.4M | ||
| Q2 25 | $85.6M | $96.0M | ||
| Q1 25 | $88.3M | $93.2M | ||
| Q4 24 | $315.7M | $101.0M | ||
| Q3 24 | $361.1M | $96.7M | ||
| Q2 24 | $345.5M | $96.8M | ||
| Q1 24 | $390.8M | $107.2M |
总债务CHGGPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益CHGGPBYI
| Q4 25 | $119.6M | $130.3M | ||
| Q3 25 | $146.1M | $115.3M | ||
| Q2 25 | $157.9M | $104.7M | ||
| Q1 25 | $185.7M | $97.1M | ||
| Q4 24 | $193.0M | $92.1M | ||
| Q3 24 | $185.0M | $71.1M | ||
| Q2 24 | $365.5M | $48.5M | ||
| Q1 24 | $963.5M | $51.0M |
总资产CHGGPBYI
| Q4 25 | $278.0M | $216.3M | ||
| Q3 25 | $378.3M | $202.9M | ||
| Q2 25 | $404.5M | $194.9M | ||
| Q1 25 | $438.8M | $196.2M | ||
| Q4 24 | $869.0M | $213.3M | ||
| Q3 24 | $1.0B | $220.7M | ||
| Q2 24 | $1.1B | $205.0M | ||
| Q1 24 | $1.7B | $214.1M |
负债/权益比CHGGPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-9.0M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $-15.5M | $14.4M |
| 自由现金流率自由现金流/营收 | -21.3% | 19.1% |
| 资本支出强度资本支出/营收 | 8.9% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-12.6M | $41.7M |
8季度趋势，按日历期对齐
经营现金流CHGGPBYI
| Q4 25 | $-9.0M | $14.4M | ||
| Q3 25 | $4.8M | $9.7M | ||
| Q2 25 | $-4.8M | $14.1M | ||
| Q1 25 | $24.5M | $3.6M | ||
| Q4 24 | $18.1M | $15.6M | ||
| Q3 24 | $39.5M | $11.0M | ||
| Q2 24 | $14.2M | $1.0M | ||
| Q1 24 | $53.3M | $11.2M |
自由现金流CHGGPBYI
| Q4 25 | $-15.5M | $14.4M | ||
| Q3 25 | $-943.0K | $9.7M | ||
| Q2 25 | $-12.1M | $14.1M | ||
| Q1 25 | $15.9M | $3.6M | ||
| Q4 24 | $4.8M | $15.6M | ||
| Q3 24 | $23.7M | $11.0M | ||
| Q2 24 | $-3.6M | $1.0M | ||
| Q1 24 | $25.3M | — |
自由现金流率CHGGPBYI
| Q4 25 | -21.3% | 19.1% | ||
| Q3 25 | -1.2% | 17.7% | ||
| Q2 25 | -11.5% | 26.8% | ||
| Q1 25 | 13.1% | 7.7% | ||
| Q4 24 | 3.4% | 26.4% | ||
| Q3 24 | 17.3% | 13.7% | ||
| Q2 24 | -2.2% | 2.1% | ||
| Q1 24 | 14.5% | — |
资本支出强度CHGGPBYI
| Q4 25 | 8.9% | 0.0% | ||
| Q3 25 | 7.4% | 0.0% | ||
| Q2 25 | 6.9% | 0.0% | ||
| Q1 25 | 7.1% | 0.1% | ||
| Q4 24 | 9.3% | 0.0% | ||
| Q3 24 | 11.6% | 0.0% | ||
| Q2 24 | 10.9% | 0.0% | ||
| Q1 24 | 16.1% | 0.0% |
现金转化率CHGGPBYI
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
